Botanical species · safety record

Commiphora mukul

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 adverse-effect records for Commiphora mukul. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Commiphora mukul (Hook. ex Stocks) Engl.

4Constituent measurements

2Safety records

4Cited sources

22Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 22 licensed products naming Commiphora mukul as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Gum
Gum oleoresin
Gum resin
Gum-resin
Oleo-gum resin
Oleo-gum-resin extract
Plant
Resin

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Live plants	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Live plants	Solvent extraction	—	Phytochemical screening	Resolve DOI
Eugenol	Unspecified	Essential oil	—	Gaschromatography (GC)	No resolvable identifier
Myrcene	Unspecified	Essential oil	—	Gaschromatography (GC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Hemopoietic	—	Unspecified	—	Human (as organism)	Subchronic	Resolve DOI
Not reported	—	—	—	Human (as organism)	Not reported	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Saxena, V. K., Sharma, R. N. Constituents of the essential oil from Commiphora mukul gum resin. Journal of medicinal and aromatic plant sciences, 1998, vol. 20, no. 1, p. 55-56.
Bhatti, H.B.A., Gogtay, N.J., Kochar, N.R., Daivi, S.S., Kshirsagar, N.A. Adverse drug reactions to Indian traditional remedies: Past, present and future. Adverse drug reaction bulletin, 2004, no. 225, p. 1-4.
Bianchi, A., Cantu, P., Firenzuoli, F., Mazzanti, G., Menniti-Ippolito, F., Raschetti, R. Rhabdomyolysis caused by Commiphora mukul, a natural lipid-lowering agent . Annals of pharmacotherapy, 2004, vol. 38, no. 7-8, p. 1222-1225. DOI
Pendyala, V., Janga, R.B., Suryadevara, V. Phytochemical and pharmacological evaluation of Commiphora mukul for antidepressant activity in albino mice. Asian journal of pharmaceutical and clinical research, 2017, vol. 10, no. 1, p. 360-363. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature